Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
4.480
+0.200 (4.67%)
At close: Feb 13, 2026, 4:00 PM EST
4.470
-0.010 (-0.22%)
After-hours: Feb 13, 2026, 7:37 PM EST

Tharimmune Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
6.846.045.94.61.370.67
Research & Development
3.56.393.562.281.840.85
Operating Expenses
10.3412.439.466.883.211.52
Operating Income
-10.34-12.43-9.46-6.88-3.21-1.52
Interest Expense
-0.03-0.01-0.02-1.59-0.83-0.25
Interest & Investment Income
0.040.250.15---
EBT Excluding Unusual Items
-10.32-12.2-9.32-8.47-4.04-1.77
Other Unusual Items
----1.83-0.36
Pretax Income
-10.32-12.2-9.32-8.47-2.21-2.42
Net Income
-10.32-12.2-9.32-8.47-2.21-2.42
Net Income to Common
-10.32-12.2-9.32-8.47-2.21-2.42
Shares Outstanding (Basic)
310000
Shares Outstanding (Diluted)
310000
Shares Change (YoY)
272.29%1388.64%188.54%78.02%0.16%54.28%
EPS (Basic)
-3.05-9.41-107.02-280.76-130.16-142.82
EPS (Diluted)
-3.05-9.41-107.02-280.76-130.16-142.82
EBIT
-10.34-12.43-9.46-6.88-3.21-1.52
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q